Unknown

Dataset Information

0

The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations.


ABSTRACT: PMM2-CDG is an autosomal recessive disorder and the most frequent form of congenital disorder of N-glycosylation, with more than 100 mutations identified to date. Sixty-six patients from 58 unrelated families were diagnosed as PMM2-CDG (CDG-Ia) based on clinical signs or because of a previous affected sibling. They all presented a type 1 serum transferrin isoform pattern, and, in most cases, the disease was confirmed by determining PMM2 activity in fibroblasts and/or lymphocytes. Residual PMM2 activity in fibroblasts ranged from not detectable to 60% of the mean controls. DNA and RNA were isolated from fresh blood or fibroblasts from patients to perform molecular studies of the PMM2 gene, resulting in the identification of 30 different mutations, four of them newly reported here (p.Y102C, p.T118S, p.P184T, and p.D209G). From these 30 mutations, 15 have only been identified among Iberian PMM2-CDG patients. As in other Caucasian populations, p.R141H was the most frequent mutation (24 alleles, prevalence 20.6%), but less than in other European series in which this mutation represents 35-43% of the disease alleles. The next frequent mutations were p.D65Y (12 alleles, prevalence 10.3%) and p.T237M (9 alleles, prevalence 7.6%), while p.F119L and p.E139K, the most frequent changes in Scandinavian and French populations, respectively, were not found in our patients. The most common genotype was [p.R141H]?+?[p.T237M], and four homozygous patients for p.Y64C, p.D65Y, p.P113L, and p.T237M were detected. The broad mutational spectrum and the diversity of phenotypes found in the Iberian populations hamper genotype-phenotype correlation.

SUBMITTER: Perez B 

PROVIDER: S-EPMC3509825 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations.

Pérez B B   Briones P P   Quelhas D D   Artuch R R   Vega A I AI   Quintana E E   Gort L L   Ecay M J MJ   Matthijs G G   Ugarte M M   Pérez-Cerdá C C  

JIMD reports 20110622


PMM2-CDG is an autosomal recessive disorder and the most frequent form of congenital disorder of N-glycosylation, with more than 100 mutations identified to date. Sixty-six patients from 58 unrelated families were diagnosed as PMM2-CDG (CDG-Ia) based on clinical signs or because of a previous affected sibling. They all presented a type 1 serum transferrin isoform pattern, and, in most cases, the disease was confirmed by determining PMM2 activity in fibroblasts and/or lymphocytes. Residual PMM2 a  ...[more]

Similar Datasets

| S-EPMC4458133 | biostudies-literature
| S-EPMC7316791 | biostudies-literature
| S-EPMC4375120 | biostudies-literature
| S-EPMC6687115 | biostudies-literature
| S-EPMC3592831 | biostudies-literature
| S-EPMC5833481 | biostudies-literature
| S-EPMC4956223 | biostudies-literature
| S-EPMC7486925 | biostudies-literature
| S-EPMC2846133 | biostudies-literature
| S-EPMC4441004 | biostudies-literature